U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation

Sung Mi Park1, Jianhong Ou2, Lynn Chamberlain1

  • 1Howard Hughes Medical Institute, Chevy Chase, MD 20815-6789, USA; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Molecular Cell
|May 18, 2016
PubMed

Insights

Oncogenic U2AF35 mutations in cancer lead to abnormal processing of autophagy gene Atg7 pre-mRNA. This defect causes decreased ATG7 levels, promoting transformation and disease development.

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • RNA Processing

Background:

  • Recurrent mutations in splicing factor U2AF35 are implicated in cancers and myelodysplastic syndrome (MDS).
  • The precise mechanisms by which oncogenic U2AF35 mutants drive cellular transformation are not fully understood.

Purpose of the Study:

  • To investigate how the oncogenic U2AF35(S34F) mutant transforms cells.
  • To identify aberrantly processed pre-mRNAs in U2AF35(S34F)-transformed cells.

Main Methods:

  • Generation of cell lines transformed by the U2AF35(S34F) mutant.
  • Deep sequencing to identify aberrant pre-mRNA processing.
  • Analysis of autophagy-related factor 7 (Atg7) pre-mRNA processing and ATG7 protein levels.

Main Results:

  • U2AF35(S34F) transformation results in abnormal processing of Atg7 pre-mRNA, specifically through selection of a distal cleavage and polyadenylation (CP) site.
  • This leads to a longer Atg7 mRNA variant with inefficient translation, causing decreased ATG7 levels and an autophagy defect.
  • MDS and acute myeloid leukemia patient samples with U2AF35(S34F) mutations exhibit increased usage of the ATG7 distal CP site.

Conclusions:

  • The U2AF35(S34F) mutation promotes transformation by disrupting Atg7 pre-mRNA processing, leading to an autophagy defect.
  • This defect predisposes cells to secondary mutations, contributing to cancer development.
  • The findings reveal a novel mechanism for U2AF35 oncogenic activity in myeloid malignancies.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.7K
Pre-mRNA Processing: Modification of pre-mRNA Ends01:35

Pre-mRNA Processing: Modification of pre-mRNA Ends

In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
17.0K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.4K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.8K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
12.1K
pre-mRNA Processing02:01

pre-mRNA Processing

In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
58.0K